In particular, the TGF-β1 SMAD2/3 pathway is significantly increased in CC14-induced mice as compared to normal mice, while the TGF-β1 inhibitor (SB431542) significantly attenuated liver fibrosis and TGF-β1 SMAD2/3 [20]. Here, SMAD2 is linked to Hepatic fibrosis.